维普期刊资源整合服务平台（V6.5）

66篇 您的检索式：作者名="COGNETTI F"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group显示文摘	Marry M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
2	Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor 2-positive metastatic breast cancer administered as first-line treatment:the M77001 study group显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
3	Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with do- cetaxel in patients with human epidermal growth factor receptor 2- positive metastatic breast cancer administered as first-line treat- ment: The M77001 study group 显示文摘	Marry M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
4	Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group显示文摘	Marry M Cognetti F Maraninehi D	2005	J Clin Oncol2005，23，19：	1
5	Trastuzumab (lderceptin) plus docetaxel versus docetaxel alone as first line treatment of HER2-positive me- tastatic breast cancer (MBC) : results of a randomised muhicentre trial显示文摘	SExtra JM Cognetti F Maraninchi D et at	2004	Eur J Cancer2004，，12：	1
6	Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: The M77001 study group 显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，3，：	1
7	Randomized phase Htrial of the efficacy and safety of trastuzumab combined withdocetaxel in patients with human epidermal growth factor receptor2-positive metastatic breast cancer administered as first-linetreatment : the M77001 study group 显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，42：	1
8	672 Randomised phase Ⅱ trial (M77001) of trastuzumab (Herceptin(R显示文摘	Extra J M Cognetti F Chan S		0，，05：	1
9	Future directions in the second - line treatment of non - small cell lung cancer显示文摘	Rosell R Cecere F Cognetti F	2006	Semin Oncol2006，33，11：	1
10	Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2 - positive metastatic breast cancer administered, as first-line treatment: The M77001 study group 显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
11	Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment:the M77001 study group显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
12	New drugs in the treatment of recurrent or metastatic cervical cancer显示文摘	Savarese A Cognetti F	2003	Crit Rev Oncol Hematol2003，48，3：	1
13	Trastuzumab (Herceptin) plus docetaxel versus docetaxel alone as first-line treatment of HER2-positive metastatic breast cancer (MBC):results of a randomised multicentre trial显示文摘	EXTRA J M COGNETTI F MARANICHI D	2004	Eur J Cancer Suppl2004，2，3：	1
14	New drugs in the treatment of recurrent or metastatic cervical cancer显示文摘	SAVARESE A COGNETTI F	2003	Crit Rev Oncol Hematol2003，45，3：	1
15	Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group显示文摘	Marry M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
16	Future Directions in the Second-line Treatment of NSCLC显示文摘	ROSELL R CECCRE F COGNETTI F	2006	J Semin in Oncol2006，33，：	1
17	Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，25，19：	1
18	Phase clinical trial of ixabepilone (BMS 247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy显示文摘	Roche H Yelle L Cognetti F	2007	J Clin 0ncol2007，25，34：	1
19	Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxelin patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 Study Group 显示文摘	Marty M Cognetti F Maranichi D	2005	J Clin Oncol2005，23，19：	1
20	Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in pa- tients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oneol2005，23，19：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示